文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

qSOFA与SIRS对疑诊脓毒症患者ICU外不良结局预测能力的比较

Comparison of qSOFA and SIRS for predicting adverse outcomes of patients with suspicion of sepsis outside the intensive care unit.
PubMed 文献 · Crit Care · 2017-03-26
一句话结论在疑诊感染且最终需入ICU的患者中,入ICU前计算的qSOFA对院内死亡和ICU-free days的判别能力优于SIRS,但对无呼吸机天数及器官功能障碍-free days的优劣尚不明确。

该研究基于Weill Cornell Medicine危重症患者注册与生物样本库的前瞻性队列,纳入152例在急诊或病房疑诊感染、随后收入内科ICU的患者(67%来自急诊),用入ICU前8小时内的生命体征计算qSOFA与SIRS评分。qSOFA预测院内死亡的AUC为0.74(95%CI 0.66-0.81),显著高于SIRS的0.59(95%CI 0.51-0.67;p=0.03);qSOFA对ICU-free days的判别也优于SIRS(p=0.04),但对无呼吸机天数(p=0.19)、任何器官功能障碍-free days(p=0.13)及肾功能障碍-free days(p=0.17)的判别差异无统计学意义。作者认为这些结果有助于临床医生进一步理解qSOFA的实用性。

要点

  • 疑诊感染且最终收入ICU的患者中,入ICU前qSOFA预测院内死亡的AUC为0.74(95%CI 0.66-0.81),SIRS为0.59(95%CI 0.51-0.67),qSOFA显著更优(p=0.03)。
  • qSOFA对ICU-free days的判别优于SIRS(p=0.04)。
  • qSOFA对无呼吸机天数(p=0.19)、任何器官功能障碍-free days(p=0.13)、肾功能障碍-free days(p=0.17)的判别与SIRS无显著差异。
  • 研究人群152例,67%来自急诊,67%培养阳性,院内死亡率19%。
  • qSOFA与SIRS评分均在入ICU前8小时内计算。

适用人群与场景

  • 急诊科或医院病房中疑诊感染、随后收入内科ICU并纳入Weill Cornell Medicine危重症患者注册与生物样本库的患者。
  • 共152例,67%来自急诊科。

诊断标准与关键阈值

  • qSOFA与SIRS评分均在ICU外计算,具体为入ICU前8小时内。

研究设计与关键结果

  • 研究类型为基于正在进行的危重症患者前瞻性队列(Weill Cornell Medicine Registry and Biobank of Critically Ill Patients)的分析,样本量152例,67%来自急诊科,67%培养阳性,19%院内死亡。
  • 主要终点:qSOFA预测院内死亡的AUC为0.74(95%CI 0.66-0.81),SIRS为0.59(95%CI 0.51-0.67),qSOFA显著优于SIRS(p=0.03)。
  • 关键次要终点:qSOFA对ICU-free days的判别优于SIRS(p=0.04);对无呼吸机天数(p=0.19)、任何器官功能障碍-free days(p=0.13)、肾功能障碍-free days(p=0.17)的判别与SIRS无显著差异。

证据类型、等级与局限

  • 证据类型:基于前瞻性队列的观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在疑诊感染且最终需入ICU的患者中,入ICU前计算的qSOFA对院内死亡和ICU-free days的判别能力优于SIRS,作者认为这些发现可能有助于临床医生进一步理解qSOFA的实用性。
  • 原文结论指出,qSOFA是否同样优于SIRS预测无呼吸机天数和器官功能障碍-free days尚不明确。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) Task Force recently introduced a new clinical score termed quick Sequential (Sepsis-related) Organ Failure Assessment (qSOFA) for identification of patients at risk of sepsis outside the intensive care unit (ICU). We attempted to compare the discriminatory capacity of the qSOFA versus the Systemic Inflammatory Response Syndrome (SIRS) score for predicting mortality, ICU-free days, and organ dysfunction-free days in patients with suspicion of infection outside the ICU.

METHODS: The Weill Cornell Medicine Registry and Biobank of Critically Ill Patients is an ongoing cohort of critically ill patients, for whom biological samples and clinical information (including vital signs before and during ICU hospitalization) are prospectively collected. Using such information, qSOFA and SIRS scores outside the ICU (specifically, within 8 hours before ICU admission) were calculated. This study population was therefore comprised of patients in the emergency department or the hospital wards who had suspected infection, were subsequently admitted to the medical ICU and were included in the Registry and Biobank.

RESULTS: One hundred fifty-two patients (67% from the emergency department) were included in this study. Sixty-seven percent had positive cultures and 19% died in the hospital. Discrimination of in-hospital mortality using qSOFA [area under the receiver operating characteristic curve (AUC), 0.74; 95% confidence intervals (CI), 0.66-0.81] was significantly greater compared with SIRS criteria (AUC, 0.59; 95% CI, 0.51-0.67; p = 0.03). The qSOFA performed better than SIRS regarding discrimination for ICU-free days (p = 0.04), but not for ventilator-free days (p = 0.19), any organ dysfunction-free days (p = 0.13), or renal dysfunction-free days (p = 0.17).

CONCLUSIONS: In patients with suspected infection who eventually required admission to the ICU, qSOFA calculated before their ICU admission had greater accuracy than SIRS for predicting mortality and ICU-free days. However, it may be less clear whether qSOFA is also better than SIRS criteria for predicting ventilator free-days and organ dysfunction-free days. These findings may help clinicians gain further insight into the usefulness of qSOFA.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Finkelsztein EJ, Jones DS, Ma KC, et al. Comparison of qSOFA and SIRS for predicting adverse outcomes of patients with suspicion of sepsis outside the intensive care unit. Crit Care. 2017. PMID: 28342442. doi:10.1186/s13054-017-1658-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。